Fig. 1 · Structure
Documents & Downloads
Tixentamig
Monoclonal Antibody
Tixentamig is a bispecific monoclonal antibody that targets human CD3 ε and Claudin 18 (CLDN18). This compound enhances T cell-mediated cytotoxicity against cancer cells expressing CLDN18, making it a valuable tool for cancer immunotherapy research. Its dual targeting mechanism offers potential insights into tumor microenvironment interactions and immune response modulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2969220-04-8 |
| Applications | Monoclonal Antibody |
| Molecular Weight | 126.158 kDa |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.